Stericycle (NASDAQ:SRCL) Issues Earnings Results, Beats Estimates By $0.03 EPS

Stericycle (NASDAQ:SRCL) issued its quarterly earnings results on Thursday. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03, Briefing.com reports. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was down 2.8% on a year-over-year basis. Stericycle updated its FY 2024 guidance to 2.200-2.500 EPS.

Stericycle Trading Down 0.4 %

Shares of NASDAQ:SRCL opened at $46.31 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.94 and a current ratio of 1.11. The company has a fifty day simple moving average of $51.35 and a 200 day simple moving average of $48.17. Stericycle has a 12-month low of $37.78 and a 12-month high of $57.06.

Analyst Ratings Changes

A number of research analysts recently issued reports on SRCL shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. Stifel Nicolaus lifted their target price on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. Wells Fargo & Company boosted their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. StockNews.com cut shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Finally, Robert W. Baird lowered their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research note on Friday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $60.80.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.